Stocks Under $10: Intermolecular

Richard Suttmeier  |

Intermolecular (IMI) – ($8.30) has been downgraded to Hold from Buy rating according to ValuEngine with fair value at $7.65, which makes the stock 12.3% overvalued. The one-year price target is $8.88. ValuEngine Profile – “Intermolecular, Inc. provides high productivity combinatorial technology products and services in order to accelerate research and development, innovation and time-to-market for the semiconductor and clean-energy industries. It also develops technology and intellectual property for its customers. The Company's customers include semiconductor device, semiconductor materials and equipment, and clean-energy companies. Intermolecular, Inc. is headquartered in San Jose, California.”  

Analysis – The daily chart for IMI shows flat momentum with the stock above its 200-day simple moving average at $8.27 and below its 21-day and 50-day simple moving averages at $8.36 and $9.00. My weekly value level is $7.36 with a monthly risky level at $9.64.

Courtesy of Thomson / Reuters

 

Profiting From Energy Efficient Cryptocurrency Mining

Ticker

Company Name

Mkt Price

Fair Value

One-Year Price Target

Last 12-Mon Retn (%)

5-Yr Avg Retn (%)

P/E Ratio

IMI

INTERMOLECULAR

8.30

7.65

8.88

29.76

n/a

117.14

 

If you have any questions, please contact me at Rsuttmeier@gmail.com.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Trending Articles

Online Sales Declined on Black Friday and Cyber Monday for First Time
Profiting From Energy Efficient Cryptocurrency Mining
Is AI Ready for Prime Time: Jeff Kagan
Stocks Close Broadly Lower as Powell Signals Faster Tapering by Fed
UK Regulator Rules Facebook Must Sell Giphy
US Bank Profits Slip 1.2% in Q3
Omicron Variant Reached Europe Earlier Than Previously Thought
Vaccine Stocks Soar Amid Omicron-Related Volatility

Market Movers

Sponsored Financial Content